Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study
Authors:
- Ângela Cristine Bersch-FerreiraÂBÂngela Cristine Bersch-Ferreira
- Geni Rodrigues SampaioGSGeni Rodrigues Sampaio
- Marcella Omena GehringerMGMarcella Omena Gehringer
- Elizabeth Aparecida Ferraz da Silva TorresETElizabeth Aparecida Ferraz da Silva Torres
- Maria Beatriz Ross-FernandesMRMaria Beatriz Ross-Fernandes
- Jacqueline Tereza da SilvaJSJacqueline Tereza da Silva
- Camila Ragne TorreglosaCTCamila Ragne Torreglosa
- Cristiane KovacsCKCristiane Kovacs
- Renata AlvesRARenata Alves
- Carlos Daniel MagnoniCMCarlos Daniel Magnoni
- Bernardete WeberBWBernardete Weber
- Marcelo Macedo RogeroMRMarcelo Macedo Rogero
Open Access
- 21 February 2018
- journal article
- research article
- Published by Springer Nature in Nutrition Journal
- Vol. 17 (1) , 1-10
Abstract
Proinflammatory biomarkers levels are increased among patients with cardiovascular disease, and it is known that both the presence of insulin resistance and diet may influence those levels. However, these associations are not well studied among patients with established cardiovascular disease. Our objective is to compare inflammatory biomarker levels among cardiovascular disease secondary prevention patients with and without insulin resistance, and to evaluate if there is any association between plasma fatty acid levels and inflammatory biomarker levels among them. In this cross-sectional sub-study from the BALANCE Program Trial, we collected data from 359 patients with established cardiovascular disease. Plasma fatty acids and inflammatory biomarkers (interleukin (IL)-1β, IL-6, IL-8, IL-10, IL-12, high sensitive C-reactive protein (hs-CRP), adiponectin, and tumor necrosis factor (TNF)-alpha) were measured. Biomarkers and plasma fatty acid levels of subjects across insulin resistant and not insulin resistant groups were compared, and general linear models were used to examine the association between plasma fatty acids and inflammatory biomarkers. Subjects with insulin resistance had a higher concentration of hs-CRP (p = 0.002) and IL-6 (p = 0.002) than subjects without insulin resistance. Among subjects without insulin resistance there was a positive association between stearic fatty acid and IL-6 (p = 0.032), and a negative association between alpha-linolenic fatty acid and pro-inflammatory biomarkers (p < 0.05). Among those with insulin resistance there was a positive association between monounsaturated fatty acids and arachidonic fatty acid and adiponectin (p < 0.05), and a negative association between monounsaturated and polyunsaturated fatty acids and pro-inflammatory biomarkers (p < 0.05), as well as a negative association between polyunsaturated fatty acids and adiponectin (p < 0.05). Our study has not found any association between hs-CRP and plasma fatty acids. Subjects in secondary prevention for cardiovascular disease with insulin resistance have a higher concentration of hs-CRP and IL-6 than individuals without insulin resistance, and these inflammatory biomarkers are positively associated with saturated fatty acids and negatively associated with unsaturated fatty acids.Keywords
This publication has 47 references indexed in Scilit:
- Association between polyunsaturated fatty acids and inflammatory markers in patients in secondary prevention of cardiovascular diseaseNutrition, 2017
- AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 UpdateCirculation, 2011
- Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid–induced ceramide biosynthesis in miceJournal of Clinical Investigation, 2011
- Saturated Fat and Cardiometabolic Risk Factors, Coronary Heart Disease, Stroke, and Diabetes: a Fresh Look at the EvidenceLipids, 2010
- Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarctionThrombosis Research, 2006
- Identification of Individuals With Insulin Resistance Using Routine Clinical MeasurementsDiabetes, 2005
- Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and PreventionCirculation, 2003
- Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss*The Journal of Clinical Endocrinology & Metabolism, 2000
- An Adipocyte-Derived Plasma Protein, Adiponectin, Adheres to Injured Vascular WallsHormone and Metabolic Research, 2000
- Interleukin-6 stimulates hepatic triglyceride secretion in rats.Endocrinology, 1995